Literature DB >> 21326945

Unloading RNAs in the cytoplasm: an "importin" task.

Sandra Mg Dias1, Richard A Cerione, Kristin F Wilson.   

Abstract

The nuclear cap-binding complex (CBC), a heterodimer comprised of a 20 kDa subunit (CBP20) and an 80 kDa regulatory subunit (CBP80), binds to nascent RNA polymerase II transcripts and is important throughout different aspects of RNA metabolism. In a recent publication, using a combination of X-ray crystallographic information, mutagenesis studies, small-angle scattering experiments, analytical ultracentrifugation and in vivo assays, we presented evidence that importin-α and importin-β, two nucleocytoplasmic transport proteins, play key roles in regulating the binding of capped RNA by the CBC in cells. A model for how complexes between CBC and the importins cycle in and out of the nucleus and direct the proper positional binding and release of capped RNA is presented here and is discussed in light of recent publications.

Entities:  

Keywords:  CBC regulation; cap binding protein; capped U snRNA; capped mRNA; importin-α; importin-β

Mesh:

Substances:

Year:  2009        PMID: 21326945      PMCID: PMC3030688          DOI: 10.4161/nucl.1.2.10919

Source DB:  PubMed          Journal:  Nucleus        ISSN: 1949-1034            Impact factor:   4.197


  26 in total

1.  Evidence for a pioneer round of mRNA translation: mRNAs subject to nonsense-mediated decay in mammalian cells are bound by CBP80 and CBP20.

Authors:  Y Ishigaki; X Li; G Serin; L E Maquat
Journal:  Cell       Date:  2001-09-07       Impact factor: 41.582

2.  Cdc42 stimulates RNA splicing via the S6 kinase and a novel S6 kinase target, the nuclear cap-binding complex.

Authors:  K F Wilson; W J Wu; R A Cerione
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

3.  The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling.

Authors:  Fabrice Lejeune; Yasuhito Ishigaki; Xiaojie Li; Lynne E Maquat
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

4.  Inference of macromolecular assemblies from crystalline state.

Authors:  Evgeny Krissinel; Kim Henrick
Journal:  J Mol Biol       Date:  2007-05-13       Impact factor: 5.469

5.  Comprehensive analysis of diverse ribonucleoprotein complexes.

Authors:  Marlene Oeffinger; Karen E Wei; Richard Rogers; Jeffrey A DeGrasse; Brian T Chait; John D Aitchison; Michael P Rout
Journal:  Nat Methods       Date:  2007-10-07       Impact factor: 28.547

6.  Remodeling of the pioneer translation initiation complex involves translation and the karyopherin importin beta.

Authors:  Hanae Sato; Lynne E Maquat
Journal:  Genes Dev       Date:  2009-11-01       Impact factor: 11.361

7.  Large-scale induced fit recognition of an m(7)GpppG cap analogue by the human nuclear cap-binding complex.

Authors:  Catherine Mazza; Alexandra Segref; Iain W Mattaj; Stephen Cusack
Journal:  EMBO J       Date:  2002-10-15       Impact factor: 11.598

8.  The molecular basis for the regulation of the cap-binding complex by the importins.

Authors:  Sandra M G Dias; Kristin F Wilson; Katherine S Rojas; Andre L B Ambrosio; Richard A Cerione
Journal:  Nat Struct Mol Biol       Date:  2009-08-09       Impact factor: 15.369

9.  Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.

Authors:  Anna Niedzwiecka; Joseph Marcotrigiano; Janusz Stepinski; Marzena Jankowska-Anyszka; Aleksandra Wyslouch-Cieszynska; Michal Dadlez; Anne-Claude Gingras; Pawel Mak; Edward Darzynkiewicz; Nahum Sonenberg; Stephen K Burley; Ryszard Stolarski
Journal:  J Mol Biol       Date:  2002-06-07       Impact factor: 5.469

10.  Diverse role of three tyrosines in binding of the RNA 5' cap to the human nuclear cap binding complex.

Authors:  Remigiusz Worch; Marzena Jankowska-Anyszka; Anna Niedzwiecka; Janusz Stepinski; Catherine Mazza; Edward Darzynkiewicz; Stephen Cusack; Ryszard Stolarski
Journal:  J Mol Biol       Date:  2008-11-08       Impact factor: 5.469

View more
  8 in total

1.  Improved methodology for the affinity isolation of human protein complexes expressed at near endogenous levels.

Authors:  Michal Domanski; Kelly Molloy; Hua Jiang; Brian T Chait; Michael P Rout; Torben Heick Jensen; John LaCava
Journal:  Biotechniques       Date:  2012-05       Impact factor: 1.993

Review 2.  The coming-of-age of nucleocytoplasmic transport in motor neuron disease and neurodegeneration.

Authors:  Paulo A Ferreira
Journal:  Cell Mol Life Sci       Date:  2019-02-11       Impact factor: 9.261

3.  Binding properties and dynamic localization of an alternative isoform of the cap-binding complex subunit CBP20.

Authors:  Marta Pabis; Noa Neufeld; Yaron Shav-Tal; Karla M Neugebauer
Journal:  Nucleus       Date:  2010 Sep-Oct       Impact factor: 4.197

4.  Human-like PB2 627K influenza virus polymerase activity is regulated by importin-α1 and -α7.

Authors:  Ben Hudjetz; Gülsah Gabriel
Journal:  PLoS Pathog       Date:  2012-01-19       Impact factor: 6.823

5.  The TAL effector PthA4 interacts with nuclear factors involved in RNA-dependent processes including a HMG protein that selectively binds poly(U) RNA.

Authors:  Tiago Antonio de Souza; Adriana Santos Soprano; Nayara Patricia Vieira de Lira; Alexandre José Christino Quaresma; Bianca Alves Pauletti; Adriana Franco Paes Leme; Celso Eduardo Benedetti
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 6.  Cap-binding complex (CBC).

Authors:  Thomas Gonatopoulos-Pournatzis; Victoria H Cowling
Journal:  Biochem J       Date:  2014-01-15       Impact factor: 3.857

7.  Hop-on hop-off: importin-α-guided tours to the nucleus in innate immune signaling.

Authors:  Lennart Wirthmueller; Charlotte Roth; Mark J Banfield; Marcel Wiermer
Journal:  Front Plant Sci       Date:  2013-05-21       Impact factor: 5.753

Review 8.  The dharma of nonsense-mediated mRNA decay in mammalian cells.

Authors:  Maximilian Wei-Lin Popp; Lynne E Maquat
Journal:  Mol Cells       Date:  2014-01-27       Impact factor: 5.034

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.